320 related articles for article (PubMed ID: 28751163)
1. Leishmaniasis in the major endemic region of Plurinational State of Bolivia: Species identification, phylogeography and drug susceptibility implications.
Bilbao-Ramos P; Dea-Ayuela MA; Cardenas-Alegría O; Salamanca E; Santalla-Vargas JA; Benito C; Flores N; Bolás-Fernández F
Acta Trop; 2017 Dec; 176():150-161. PubMed ID: 28751163
[TBL] [Abstract][Full Text] [Related]
2. Influence of Leishmania (Viannia) species on the response to antimonial treatment in patients with American tegumentary leishmaniasis.
Arevalo J; Ramirez L; Adaui V; Zimic M; Tulliano G; Miranda-Verástegui C; Lazo M; Loayza-Muro R; De Doncker S; Maurer A; Chappuis F; Dujardin JC; Llanos-Cuentas A
J Infect Dis; 2007 Jun; 195(12):1846-51. PubMed ID: 17492601
[TBL] [Abstract][Full Text] [Related]
3. Detection of Internal Transcribed Spacer 1 and hsp70 Genetic Markers Using Restriction Fragment Length Polymorphisms and Sequencing in Identification of Leishmania Species Causing Tegumentary Leishmaniasis in Brazil.
Delprete JA; de Almeida LV; Barros AM; Soler RC; Bittencourt AA; Luna EJA; Lindoso JAL; Braz LMA
Am J Trop Med Hyg; 2024 Jan; 110(1):52-58. PubMed ID: 38081057
[TBL] [Abstract][Full Text] [Related]
4. Drug resistance in leishmaniasis: its implication in systemic chemotherapy of cutaneous and mucocutaneous disease.
Grogl M; Thomason TN; Franke ED
Am J Trop Med Hyg; 1992 Jul; 47(1):117-26. PubMed ID: 1322070
[TBL] [Abstract][Full Text] [Related]
5. In vitro sensitivity of Leishmania (Viannia) braziliensis and Leishmania (Leishmania) amazonensis Brazilian isolates to meglumine antimoniate and amphotericin B.
Zauli-Nascimento RC; Miguel DC; Yokoyama-Yasunaka JK; Pereira LI; Pelli de Oliveira MA; Ribeiro-Dias F; Dorta ML; Uliana SR
Trop Med Int Health; 2010 Jan; 15(1):68-76. PubMed ID: 19874570
[TBL] [Abstract][Full Text] [Related]
6. Intraspecies susceptibility of Leishmania (Viannia) braziliensis to antileishmanial drugs: Antimony resistance in human isolates from atypical lesions.
Rugani JN; Quaresma PF; Gontijo CF; Soares RP; Monte-Neto RL
Biomed Pharmacother; 2018 Dec; 108():1170-1180. PubMed ID: 30372818
[TBL] [Abstract][Full Text] [Related]
7. First evidence of transmission of Leishmania (Viannia) lainsoni in a Sub Andean region of Bolivia.
Bastrenta B; Buitrago R; Vargas F; Le Pont F; Torrez M; Flores M; Mita N; Brenière SF
Acta Trop; 2002 Sep; 83(3):249-53. PubMed ID: 12204398
[TBL] [Abstract][Full Text] [Related]
8. PCR-RFLP of ribosomal internal transcribed spacers highlights inter and intra-species variation among Leishmania strains native to La Paz, Bolivia.
Buitrago R; Cupolillo E; Bastrenta B; Le Pont F; Martinez E; Barnabé C; Brenière SF
Infect Genet Evol; 2011 Apr; 11(3):557-63. PubMed ID: 21138774
[TBL] [Abstract][Full Text] [Related]
9. In vitro characterization of Leishmania (Viannia) braziliensis isolates from patients with different responses to Glucantime(®) treatment from Northwest Paraná, Brazil.
Fernandes AC; Pedroso RB; de Mello TF; Donatti L; Venazzi EA; Demarchi IG; Aristides SM; Lonardoni MV; Silveira TG
Exp Parasitol; 2016 Aug; 167():83-93. PubMed ID: 27181585
[TBL] [Abstract][Full Text] [Related]
10. In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.
Nieto-Meneses R; Castillo R; Hernández-Campos A; Maldonado-Rangel A; Matius-Ruiz JB; Trejo-Soto PJ; Nogueda-Torres B; Dea-Ayuela MA; Bolás-Fernández F; Méndez-Cuesta C; Yépez-Mulia L
Exp Parasitol; 2018 Jan; 184():82-89. PubMed ID: 29191699
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of miltefosine for Bolivian cutaneous leishmaniasis.
Soto J; Rea J; Balderrama M; Toledo J; Soto P; Valda L; Berman JD
Am J Trop Med Hyg; 2008 Feb; 78(2):210-1. PubMed ID: 18256415
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous leishmaniasis in Bolivia. A study of 185 human cases from Alto Beni (La Paz Department). Isolation and isoenzyme characterization of 26 strains of Leishmania braziliensis braziliensis [corrected].
Desjeux P; Mollinedo S; Le Pont F; Paredes A; Ugarte G
Trans R Soc Trop Med Hyg; 1987; 81(5):742-6. PubMed ID: 3449990
[TBL] [Abstract][Full Text] [Related]
13. Distinct genetic profiles of Leishmania (Viannia) braziliensis associate with clinical variations in cutaneous-leishmaniasis patients from an endemic area in Brazil.
Quaresma PF; de Brito CFA; Rugani JMN; Freire JM; Baptista RP; Moreno EC; Gontijo RC; Rego FD; Diniz JE; Melo MN; Gontijo CMF
Parasitology; 2018 Aug; 145(9):1161-1169. PubMed ID: 29526166
[TBL] [Abstract][Full Text] [Related]
14. First Molecular Report of
Salvioni Recalde OD; Pereira Brunelli J; Rolon MS; Rojas de Arias A; Aldama O; Gómez CV
Am J Trop Med Hyg; 2019 Oct; 101(4):780-788. PubMed ID: 31407656
[TBL] [Abstract][Full Text] [Related]
15. Molecular Identification of Parasites Causing Cutaneous Leishmaniasis in Panama.
Miranda ADC; González KA; Samudio F; Pineda VJ; Calzada JE; Capitan-Barrios Z; Jiménez A; Castillo J; Mendoza Y; Suárez JA; Ortiz B; Méndez J; Pascale JM; Grögl M; Sosa N; Saldaña A
Am J Trop Med Hyg; 2021 Jan; 104(4):1326-1334. PubMed ID: 33432903
[TBL] [Abstract][Full Text] [Related]
16. Distribution, treatment outcome and genetic diversity of Leishmania species in military personnel from Colombia with cutaneous leishmaniasis.
Correa-Cárdenas CA; Pérez J; Patino LH; Ramírez JD; Duque MC; Romero Y; Cantillo-Barraza O; Rodríguez O; Alvarado MT; Cruz C; Méndez C
BMC Infect Dis; 2020 Dec; 20(1):938. PubMed ID: 33297972
[TBL] [Abstract][Full Text] [Related]
17. Clinical complexity of Leishmania (Viannia) braziliensis infections amongst travelers.
Eichner S; Thoma-Uszynski S; Herrgott I; Sebald H; Debus A; Tsianakas A; Ehrchen J; Harms G; Simon M; Sunderkötter C; Bogdan C
Eur J Dermatol; 2013 Apr; 23(2):218-23. PubMed ID: 23557633
[TBL] [Abstract][Full Text] [Related]
18. Species diversity of Leishmania (Viannia) parasites circulating in an endemic area for cutaneous leishmaniasis located in the Atlantic rainforest region of northeastern Brazil.
Brito ME; Andrade MS; Mendonça MG; Silva CJ; Almeida EL; Lima BS; Félix SM; Abath FG; da Graça GC; Porrozzi R; Ishikawa EA; Shaw JJ; Cupolillo E; Brandão-Filho SP
Trop Med Int Health; 2009 Oct; 14(10):1278-86. PubMed ID: 19708899
[TBL] [Abstract][Full Text] [Related]
19. Sensitivity of Leishmania braziliensis promastigotes to meglumine antimoniate (glucantime) is higher than that of other Leishmania species and correlates with response to therapy in American tegumentary leishmaniasis.
Azeredo-Coutinho RB; Mendonça SC; Callahan H; Portal AC; Max G
J Parasitol; 2007 Jun; 93(3):688-93. PubMed ID: 17626365
[TBL] [Abstract][Full Text] [Related]
20. The sensitivity of clinical isolates of Leishmania from Peru and Nepal to miltefosine.
Yardley V; Croft SL; De Doncker S; Dujardin JC; Koirala S; Rijal S; Miranda C; Llanos-Cuentas A; Chappuis F
Am J Trop Med Hyg; 2005 Aug; 73(2):272-5. PubMed ID: 16103588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
